Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genix Pharmaceuticals Corp V.GENX

Alternate Symbol(s):  GENPF

Consumer Defensive Industrials Household & Personal Products Business Services
Genix Pharmaceuticals Corporation is a nutraceutical and generic ophthalmic drugs company. The Company is focused on the research, development, manufacturing, licensing, and sales of healthcare products. Its products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single-molecule generic drugs. The Company is engaged in marketing and selling other... see more

Recent & Breaking News (TSXV:GENX)

Genix Announces TSX-V Approval of Warrant Amendments

Newsfile February 6, 2024

Genix Announces Warrant Repricing and Seeks Extension

Newsfile January 18, 2024

Genix Announces AGM Results

Newsfile May 26, 2023

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Newsfile July 28, 2022

Genix Proposes to Extend Warrants

Newsfile July 20, 2022

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

Newsfile July 15, 2021

Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange

Newsfile June 21, 2021

Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders

Newsfile June 7, 2021

Genix Pharmaceuticals (TSXV:GENX) signs exclusive license and supply agreement for Canada’s first generic thyroid medication

Julia Kennedy  April 1, 2021

Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada's First Generic Thyroid Medication

Newsfile April 1, 2021

Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions (ANDS) for Its First Ten Ophthalmic Drugs with Health Canada

Newsfile March 22, 2021

Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director

Newsfile September 22, 2020

Genix Pharmaceuticals Corporation Announces Closing of Second Tranche Financing and Closing of Acquisition of Rights to Nutraceutical Products Sucanon(R) and Renochlor(R)

Newsfile August 6, 2020

Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement

Newsfile July 17, 2020

Genix Pharmaceuticals Corporation Announces the Extension of Payment Terms for the Acquisitions of Rights to Renochlor(R), Sucanon(R) and Flu-x(TM)

Newsfile June 30, 2020

Genix Pharmaceuticals Corporation Announces Non-Brokered Private Placement

Newsfile June 22, 2020

Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)

Newsfile March 27, 2020

Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers

Newsfile February 14, 2020

IIROC Trading Resumption - GENX

Canada NewsWire January 15, 2020

Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)

Newsfile January 14, 2020